Current report no.: 24/2023
Date of preparation: 11 September 2023
Legal basis: Article 17(1) of the MAR Regulation – inside information.
The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (the “Company“; “Issuer“) informs about significant changes in the structure of the international team of sales leaders, presented in the Company’s Strategy for 2023 – 2026, published in the Issuer’s current report No. 16/2023 of June 19, 2023. The Company informs that the new sales leader responsible for the sales area in the Company as of October 1, 2023 will be Mr. James Landis as Executive Vice President of Global Sales and Marketing, previously VP Sales and Business Development North America. In addition, in connection with the development of the Company’s sales, the Supervisory Board of the Company delegated Mr. David Cash – Member of the Supervisory Board of the Company to independently perform supervisory duties over the Company’s sales area.
The above change is also related to the planned change of the role of Mr. Jarosław Jerzakowski, Member of the Management Board of the Company, the current Chief Commercial Officer, who will perform new duties as Chief Operating Officer (COO) from October 1, 2023, where he will support the development of the Company’s business, which was covered by the resolution of the Supervisory Board approving the above changes. The function of Mr. Jarosław Jerzakowski in the Management Board of the Company, in which he is a Member of the Management Board, will not change.